ArticleInternational journal of molecular sciences2025
Distinct Spectral Profiles of Pleural Effusions from Malignant Tumors Using Raman Spectroscopy.
Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Raman spectroscopy is a powerful method in the field of cancer diagnosis, for which various sample types and measurement modalities can be used. In this study, pleural effusion samples from twenty patients with suspected malignancies were analyzed. After fluid samples were fixed with ethanol and dried, high-quality spectra were taken at three different points using two laser lines. Principal Component Analysis showed clustering of spectra from malignant samples. The results show that despite a strong fluorescence signal from blood with the 532 nm laser line, spectra collected with both 532 nm and 785 nm laser lines are complementary, as they produce different high-intensity bands; e.g., breast cancer and adenocarcinoma signals are stronger with 785 nm. The main change in cancer specimens is an increase in amino acids. In addition, in small-cell carcinoma of the lung and mesothelioma, elevated nucleic acids and lipids were observed, respectively. Raman spectroscopy shows distinct profiles for control and malignant effusions. Further investigation of the utility of spectral markers in personalized treatment could improve survival.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.